|
2024
|
Invention
|
Aptamer. The invention relates to aptamers, and to aptamers which are capable of binding specific... |
|
|
Invention
|
Neurodegenerative disease biomarkers. The invention relates to neurodegenerative disorders, and p... |
|
|
Invention
|
T14 antagonists for use in the treatment of rapamycin-sensitive conditions. The invention relates... |
|
|
Invention
|
Neurodegenerative disorders. The invention relates to a peptide derivative of Formula (I). The pe... |
|
2023
|
Invention
|
Lateral flow device for diagnosing alzheimer's disease using the t14 peptide. The invention relat... |
|
2022
|
Invention
|
Skin biomarker. The invention relates to skin biomarkers, and in particular, to skin biomarkers f... |
|
|
Invention
|
Peptide t14 for braak staging.
The invention relates to biomarkers, and particularly, although n... |
|
|
Invention
|
Peptide t14 for braak staging. The invention relates to biomarkers, and particularly, although no... |
|
2021
|
Invention
|
Nbp-14 for treating alzheimer's associated with down's syndrome.
The invention provides a cyclic... |
|
|
Invention
|
Nbp-14 for treating alzheimer's associated with down's syndrome. The invention provides a cyclic ... |
|
|
Invention
|
Neurodegenerative disorders. A cyclic polypeptide, derivative or analogue thereof, comprising an ... |
|
|
Invention
|
Cyclic peptides from the c-terminus of acetylcholinesterase for treatment of skin disorders and f... |
|
|
Invention
|
Polypeptides derived from the c-terminus of acetylcholinesterase for use in skin conditions. The ... |
|
2020
|
Invention
|
Animal model for neurodegenerative disorders.
The invention relates to animal models, and in par... |
|
|
Invention
|
Animal model for neurodegenerative disorders. The invention relates to animal models, and in part... |
|
2019
|
Invention
|
Cyclic acetylcholinesterase c-terminal peptide in the treatment or prevention of cancer or metast... |
|
2018
|
Invention
|
Biomarker.
The invention relates to biomarkers for neurodegenerative disorders, such as Alzheime... |
|
|
Invention
|
Biomarker for predicting cognitive decline. The invention relates to biomarkers for neurodegenera... |
|
2017
|
Invention
|
Modified peptides for use in treating neurodegenerative disorders. The invention relates to neuro... |
|
|
Invention
|
Cancer. The invention relates to cancer, and in particular to novel pharmaceutical compositions, ... |
|
2016
|
Invention
|
Antibody that recognises the t14 peptide of ache. The invention relates to antibodies, and in par... |
|
2015
|
Invention
|
Neurodegenerative disorders. The invention relates to novel peptides, compositions, therapies and... |
|
|
Invention
|
Peptides for use in neurodegenerative disorders. The invention relates to novel peptides, composi... |
|
2014
|
Invention
|
Neurodegenerative disorders. A cyclic polypeptide, derivative or analog thereof, comprising an am... |
|
|
Invention
|
Acetylcholinesterase-derived cyclic peptide for treating neurodegenerative disorders. Acetylcholi... |
|
|
Invention
|
Biomarkers for alzheimer's disease. The invention provides Alzheimer's disease biomarkers, and to... |
